www.fdanews.com/articles/86306-novartis-reports-31-profit-rise
NOVARTIS REPORTS 31% PROFIT RISE
April 25, 2006
The drug maker Novartis said Monday that first-quarter profit rose 31 percent from the year-earlier period, helped by demand for the hypertension treatment Diovan and a gain from the sale of its nutrition unit.
International Herald Tribune (http://www.iht.com/articles/2006/04/24/bloomberg/bxdrug.php)